×
Prestige Consumer Healthcare EBITDA 2010-2025 | PBH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Prestige Consumer Healthcare ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Prestige Consumer Healthcare EBITDA 2010-2025 | PBH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Prestige Consumer Healthcare ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$218.6B
Boston Scientific (BSX)
$157.1B
Stryker (SYK)
$151.4B
EssilorLuxottica (ESLOY)
$135B
Medtronic (MDT)
$118.4B
Lonza Group Ag (LZAGY)
$50B
Haleon (HLN)
$44.2B
ResMed (RMD)
$40.1B
GE HealthCare Technologies (GEHC)
$35.2B
Agilent Technologies (A)
$34.2B
Terumo (TRUMY)
$26B
Koninklijke Philips (PHG)
$24.9B
Insulet (PODD)
$20.2B
Zimmer Biomet Holdings (ZBH)
$19.2B
Baxter (BAX)
$14.8B
Smith & Nephew SNATS (SNN)
$13.8B
Sunny Optical Technology (SNPTF)
$10.4B
Demant (WILYY)
$8.6B
Bio-Rad Laboratories (BIO)
$7.1B
Lantheus Holdings (LNTH)
$4.9B
Perrigo (PRGO)
$3.9B
Haemonetics (HAE)
$3.6B
Envista Holdings (NVST)
$3.5B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
ICU Medical (ICUI)
$3.2B
LeMaitre Vascular (LMAT)
$1.8B
QuidelOrtho (QDEL)
$1.8B
AtriCure (ATRC)
$1.5B
Acuren (TIC)
$1.5B
Green Thumb Industries (GTBIF)
$1.3B